BiotechTube

Levofloxacin + Levofloxacin

ApprovedUNKNOWN
0 watching 0 views this week🔥 Hot
82
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Urinary Tract Infection

Conditions

Urinary Tract Infection

Trial Timeline

Apr 15, 2017 → Mar 1, 2018

NCT ID
NCT03160807

About Levofloxacin + Levofloxacin

Levofloxacin + Levofloxacin is a approved stage product being developed by Dr. Reddy's Laboratories for Urinary Tract Infection. The current trial status is unknown. This product is registered under clinical trial identifier NCT03160807. Target conditions include Urinary Tract Infection.

Hype Score Breakdown

Clinical
30
Activity
20
Company
7
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT03160807ApprovedUNKNOWN

Competing Products

20 competing products in Urinary Tract Infection

See all competitors
ProductCompanyStageHype Score
Duloxetine + placeboEli LillyPhase 2
52
DuloxetineEli LillyPhase 2
52
Enfortumab vedotinAstellas PharmaPhase 1
33
solifenacin succinate + tamsulosin + placeboAstellas PharmaApproved
85
solifenacin succinate + tamsulosin hydrochloride + Placebo to solifenacin + Placebo to tamsulosinAstellas PharmaPhase 2
52
SolifenacinAstellas PharmaApproved
85
Mirabegron + Tolterodine + Placebo to Mirabegron + Placebo to TolterodineAstellas PharmaPhase 3
77
Levofloxacin + Solifenacin succinate + Placebo (for Solifenacin succinate)Astellas PharmaApproved
85
solifenacin succinateAstellas PharmaPhase 3
77
SolifenacinAstellas PharmaPre-clinical
23
SolifenacinAstellas PharmaPre-clinical
23
TamuslosinAstellas PharmaPhase 3
77
Tamsulosin + SolifenacinAstellas PharmaApproved
85
Alpha blocker + placebo + solifenacinAstellas PharmaApproved
85
mirabegron 25 mg + mirabegron 50 mg + solifenacin 5 mg + solifenacin 10 mg + mirabegron 25 mg matching placebo + mirabegron 50 mg matching placebo + solifenacin 5 mg matching placebo + solifenacin 10 mg matching placeboAstellas PharmaPhase 3
77
solifenacin succinate + tolterodineAstellas PharmaPhase 3
77
TamusulosinAstellas PharmaPhase 3
77
SolifenacinAstellas PharmaPre-clinical
23
Solifenacin succinate + TolterodineAstellas PharmaPhase 3
77
Solifenacin succinate + PlaceboAstellas PharmaPhase 3
77

Other Products from Dr. Reddy's Laboratories

OMEZ 40 + OMEZ 80Approved
82
Ketorolac Tromethamine + KetoprofenApproved
82
omeprazole+domperidone SR + omeprazoleApproved
82
NISEApproved
82
Abametapir Lotion 0.74% w/w + Vehicle LotionPhase 3
74